Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels

BACKGROUND: Aldosterone is elevated in chronic kidney disease (CKD) and may be involved in hypertension. Surprisingly, the determinants of the plasma aldosterone concentration (PAC) and its role in hypertension are not well studied in CKD. Therefore, we studied the determinants of aldosterone and it...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Nephrol
Hauptverfasser: Gant, Christina M., Laverman, Gozewijn D., Vogt, Liffert, Slagman, Maartje C. J., Heerspink, Hiddo J. L., Waanders, Femke, Hemmelder, Marc H., Navis, Gerjan
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2017
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738866/
https://ncbi.nlm.nih.gov/pubmed/29262813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0789-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge